Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Rang in aandelen #98
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Aandeelprijs
$37.45
Marktkapitalisatie
$166.43B
Verandering (1 dag)
-2.55%
Verandering (1 jaar)
-53.09%
Land
DK
Handel Novo Nordisk A/S (NVO)

Categorie

Koersgeschiedenis voor Novo Nordisk A/S (NVO)
Hoogste slotkoers: $39.09 op 2026-03-01

Laagste slotkoers: $2.18 op 2001-06-01
Koersgeschiedenis van Novo Nordisk A/S van 2001 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 18.12%
2025 -52.88%
2024 4.19%
2023 52.36%
2022 18.41%
2021 58.33%
2020 21.90%
2019 25.31%
2018 -13.26%
2017 49.00%
2016 -38.01%
2015 27.36%
2014 25.80%
2013 10.08%
2012 42.99%
2011 5.13%
2010 62.76%
2009 25.56%
2008 -19.27%
2007 58.83%
2006 48.57%
2005 3.61%
2004 36.73%
2003 27.97%
2002 -21.30%
2001 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$451.59 -11.89%
US
$744.12 10.67%
US
$296.06 50.53%
BE
$94.95 -40.77%
AU
$684.77 10.45%
NL